Verdicts

GLP-1s vs Carnivore vs Fasting: What Actually Works for Men Over 40

Three popular interventions for men over 40 chasing body composition. Each has loud advocates and real results. Here's the honest head-to-head on effect size, sustainability, safety, and who each approach actually serves best.

Published April 2026 · 9-minute read · Evidence-based head-to-head

You're 47. You've noticed the gut. You've been reading about everyone's favorite approach. Joe Rogan is on carnivore. The biohacking podcast guy you like is running prolonged fasts. Your doctor mentioned Wegovy. Your brother-in-law tried keto and hates it. You're trying to figure out which path is actually worth committing to.

Let's do the honest head-to-head. GLP-1s, carnivore (all-meat or nearly so), and intermittent/prolonged fasting — three distinct approaches with real advocates and real success stories. But also three approaches with meaningfully different effect sizes, sustainability profiles, safety considerations, and fit for different men.

Here's what the evidence actually says and how to pick the right lane.

The three approaches in honest terms

GLP-1 Medications

Weekly injection (or daily oral) of semaglutide or tirzepatide. Reduces appetite and food noise through gut-brain hormone pathways. Originally developed for Type 2 diabetes; FDA-approved for obesity since 2021.

Typical loss (12 months)
15–22% body weight
Sustainability
High with continued use
Cost
$150–$350/mo
Effort
Low

Carnivore Diet

All animal foods — meat, eggs, some dairy — with zero or minimal plants. Marketed by Jordan Peterson, Shawn Baker, and others. Produces rapid weight loss primarily through dramatic caloric restriction (boredom with food) and high protein satiety.

Typical loss (12 months)
10–20% if sustained
Sustainability
Low for most men
Cost
$500–$900/mo food
Effort
High

Intermittent/Prolonged Fasting

Time-restricted eating (16:8, 18:6, OMAD) or longer periodic fasts (24–72+ hours). Popularized by Peter Attia, Valter Longo, biohacking community. Produces weight loss through overall caloric restriction and metabolic adaptation.

Typical loss (12 months)
5–15%
Sustainability
Moderate
Cost
$0 (even saves money)
Effort
Moderate-High

Effect size: the uncomfortable truth

When you look at what each approach actually produces over 12 months for the average man starting at ~25% body fat:

ApproachAvg weight loss (12 mo)Muscle preservationAdherence at 12 mo
GLP-1 (tirzepatide)21% (SURMOUNT-1)1Good with training + protein~85%
GLP-1 (semaglutide)15% (STEP-1)2Good with training + protein~85%
Strict carnivore10–20% (observational)Good (high protein)~20–30%
16:8 intermittent fasting3–8% (RCT meta-analyses)3Good if timed well~50–60%
Alternate-day fasting6–10%Variable~30–40%

For adherence, the gap is large. GLP-1 users stick with their protocol at ~85% one-year rates because the drug carries most of the behavioral load. Carnivore adherents drop to 20–30% by year one because eliminating every plant food forever is socially and practically difficult. Fasting adherents do better — around 50–60% — because it's more flexible and less socially constraining.

21% vs 10–20%
Typical 12-month weight loss with tirzepatide (SURMOUNT-1 RCT) vs. carnivore diet (observational data). The drug wins on effect size with substantially less behavioral load.

What each approach does well

What GLP-1s do well for men over 40

What carnivore does well

What fasting does well

Where each approach fails

Where GLP-1s fail

Where carnivore fails

Where fasting fails

The "why not combine them" question

Many men end up running hybrid protocols — GLP-1 plus time-restricted eating plus high-protein-forward diet. This is reasonable and often the best pattern for body composition:

This integrated approach takes what works from each philosophy without committing to the most extreme version. For most men over 40, this is substantially better than any pure approach.

The over-40 metabolic context

Men over 40 face specific metabolic realities that change the calculation:

Against this background, approaches that preserve muscle and address hormonal normalization are more valuable than approaches that maximize scale weight loss at the cost of lean mass.

The adherence reality

Most discussions of diet interventions ignore the central issue: whether people actually stick with them.

A useful reframe: the best diet is the one you'll actually follow for 10 years. The 20% weight loss that carnivore produces in the 20% of men who sustain it is less impactful at population level than the 10% weight loss that happens in 60% of men with a more flexible approach.

GLP-1s win this battle decisively. The drug carries the behavioral burden, so adherence at 1 year is ~85% and at 5 years remains much higher than any diet intervention.

The cardiometabolic outcomes comparison

For men with cardiovascular risk factors, the evidence strongly favors GLP-1s:

For men with established cardiovascular disease or significant risk factors, GLP-1s have evidence-based benefit that the other two approaches lack.

Who each approach serves best

GLP-1s fit best for

Carnivore fits best for

Fasting fits best for

The combined recommendation for most men over 40

For the average 45-year-old man with 30+ lbs to lose, moderate cardiovascular risk, and a normal life (family, career, social obligations), the highest-probability successful approach is:

  1. Low-dose GLP-1 maintenance (semaglutide or tirzepatide). Handles appetite and food noise.
  2. Time-restricted eating (16:8 pattern). Structures the day without rigid rules.
  3. Protein-forward diet with adequate plant food. 1 g/lb goal weight protein, heavy on meat, eggs, fish, dairy; moderate on plants for fiber and micronutrients.
  4. Resistance training 3x/week. Preserves muscle while fat is dropping.
  5. Regular labs every 6 months. Track testosterone, lipids, glucose, inflammation.

This integrated approach takes what works from each philosophy without committing to the most extreme version of any. Effect size is comparable to the best outcomes from pure interventions, with substantially better adherence and safety profile.

The foundation that makes everything else work

GLP-1 therapy is the most evidence-backed component of an effective men's protocol for over-40 body composition. Start there, layer other interventions on top as they fit your life.

Check Synergy Rx Eligibility → Synergy Rx offers physician-led GLP-1 programs with real clinical oversight. Prefer results-focused programs? SHED. Want brand-name FDA-approved prescriptions? Sesame Care via licensed US physicians.

The bottom line

GLP-1s, carnivore, and fasting are not equivalent interventions. The evidence gap is wide — GLP-1s have tens of thousands of patient-years of RCT data; carnivore and fasting have anecdote, observational data, and smaller trials.

For men over 40 with weight to lose and cardiovascular risk factors, GLP-1s produce the largest effect size with the highest adherence and the strongest safety data. The evidence-based answer is clear even when the cultural conversation isn't.

That doesn't mean carnivore and fasting have no place. Both work for specific men in specific situations. Both can be layered onto a GLP-1 protocol for hybrid approaches. Neither should be dismissed out of hand — but neither should be positioned as equivalent to the pharmacologically validated option.

If you're choosing one intervention to commit to as a man over 40: GLP-1 therapy, run well, with training and protein and reasonable nutrition, is the highest-probability winner. Layer fasting patterns onto it. Incorporate carnivore-adjacent principles (high-quality protein, plenty of animal foods, moderate plant intake) without the absolutism.

The dogmatic communities on each side want you to pick a lane. The evidence suggests a more flexible hybrid works best for most men — and that the drug component is the most impactful single piece.

Affiliate disclosure: This article contains affiliate links. GLP-1 Men may earn a commission when you sign up through our links at no additional cost to you. This article is informational only and is not medical or nutritional advice. Dietary and medical interventions should be individualized with appropriate professional guidance.

References

  1. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). NEJM, 2022.
  2. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM, 2021.
  3. Patikorn C et al. Intermittent fasting and weight change: systematic review and meta-analysis. JAMA Network Open, 2021 (and subsequent meta-analyses).
  4. Lincoff AM et al. SELECT cardiovascular outcomes. NEJM, 2023.
  5. Portillo Canales S et al. Anti-obesity medications and testosterone normalization. ENDO 2025.
  6. Wilding JPH et al. STEP 1 trial extension weight regain data. Diabetes Obes Metab, 2022.